Literature DB >> 12168305

Glial and neuronal serum markers after controlled cortical impact injury in the rat.

C Woertgen1, R D Rothoerl, M Wiesmann, U Missler, A Brawanski.   

Abstract

The aim of this study was to investigate the time course and the correlation of glial fibrillary acidic protein (GFAP), protein S-100B, and neuron specific enolase (NSE) serum levels to the severity of traumatic brain injury in rats. Male Wistar rats (n = 65 S-100B, NSE group and n = 55 GFAP group) underwent a severe cortical impact injury (100PSI, 2 mm deformation). Blood samples were drawn directly after trauma, 1 h, 6 h, 12 h, 24 h, and 48 h post trauma as well as in sham operated animals directly after craniotomy, after 6 h and 48 h. Serum levels at different severities were estimated in 20 rats (45PSI, 75PSI, 2 mm deformation). We found a time-dependent release of NSE and GFAP into serum after trauma. The highest NSE values were detected six hours after trauma (31.5 micrograms/l, mean, p < 0.0001), the highest GFAP levels were measured one hour after trauma (0.079 microgram/l, mean, p < 0.0014). Additionally we found a close relationship between NSE serum levels and the severity of traumatic brain injury (45PSI = 12.7 micrograms/l, 75PSI = 16.17 micrograms/l, 100PSI = 28.45 micrograms/l, p < 0.05). S-100B serum levels showed an increase (0.92 microgram/l, p < 0.005) but no time-dependent release. S-100B and GFAP showed no relationship to trauma severity. Serum levels of GFAP, S-100B and NSE are significantly elevated in the early phase after experimental traumatic brain injury. In this experimental model of cortical impact injury only NSE, but not GFAP and S-100B serum levels are time-dependently correlated with the severity of cortical impact.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168305     DOI: 10.1007/978-3-7091-6738-0_53

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  7 in total

1.  Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke.

Authors:  William J Savage; Allen D Everett; James F Casella
Journal:  Acta Haematol       Date:  2010-11-24       Impact factor: 2.195

2.  A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.

Authors:  Richard Rubenstein; Binggong Chang; Peter Davies; Amy K Wagner; Claudia S Robertson; Kevin K W Wang
Journal:  J Neurotrauma       Date:  2014-12-23       Impact factor: 5.269

Review 3.  [Glial fibrillary acidic protein in patients with symptoms of acute stroke: diagnostic marker of cerebral hemorrhage].

Authors:  C Foerch; W Pfeilschifter; P Zeiner; R Brunkhorst
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

4.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

5.  Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.

Authors:  Denes V Agoston; Mohammad Elsayed
Journal:  Front Neurol       Date:  2012-07-06       Impact factor: 4.003

6.  Location and level of Etk expression in neurons are associated with varied severity of traumatic brain injury.

Authors:  John Chung-Che Wu; Kai-Yun Chen; Yu-Wen Yu; Song-Wei Huang; Hsiu-Ming Shih; Wen-Ta Chiu; Yung-Hsiao Chiang; Chia-Yang Shiau
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

7.  Expression of neuron-specific enolase in multiple myeloma and implications for clinical diagnosis and treatment.

Authors:  Haiping Yang; Ruihua Mi; Qian Wang; Xudong Wei; Qingsong Yin; Lin Chen; Xinghu Zhu; Yongping Song
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.